IL-17A/F drugs for Psoriasis
4 tracked IL-17A/F drugs in the Psoriasis race. The class explanation lives on the IL-17A/F page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 41 Phase 32 Phase 2
Head-to-head evidence: bimekizumab vs Lecankitug · Lecankitug vs sonelokimab · bimekizumab vs ORKA-002 · ORKA-002 vs sonelokimab · bimekizumab vs sonelokimab